Article Text

Download PDFPDF

Exploring the enablers and barriers to implementing the Medication Appropriateness Tool for Comorbid Health conditions during Dementia (MATCH-D) criteria in Australia: a qualitative study
  1. Amy Theresa Page1,2,
  2. Rhonda Marise Clifford2,
  3. Kathleen Potter1,
  4. Liza Seubert2,
  5. Andrew J McLachlan3,4,
  6. Xaysja Hill2,
  7. Stephanie King2,
  8. Vaughan Clark2,
  9. Cristin Ryan5,
  10. Nikesh Parekh6,
  11. Christopher D Etherton-Beer1
  1. 1 Western Australian Centre for Health and Ageing, School of Medicine, University of Western Australia, Perth, Australia
  2. 2 School of Allied Health, University of Western Australia, Perth, Australia
  3. 3 Faculty of Pharmacy and Centre for Education and Research on Ageing, University of Sydney, Sydney, New South Wales, Australia
  4. 4 Concord Hospital, Sydney, New South Wales, Australia
  5. 5 School of Pharmacy, Royal College of Surgeons in Ireland, Dublin, Ireland
  6. 6 Brighton and Sussex Medical School, Brighton, UK
  1. Correspondence to Mrs Amy Theresa Page;{at}


Objectives The Medication Appropriateness Tool for Comorbid Health conditions in Dementia (MATCH-D) criteria provide expert consensus guidance about medication use for people with dementia. This study aimed to identify enablers and barriers to implementing the criteria in practice.

Setting Participants came from both rural and metropolitan communities in two Australian states.

Participants Focus groups were held with consumers, general practitioners, nurses and pharmacists. Outcomes: data were analysed thematically.

Results Nine focus groups were conducted. Fifty-five participants validated the content of MATCH-D, appraising them as providing patient-centred principles of care. Participants identified potential applications (including the use of MATCH-D as a discussion aid or educational tool for consumers about medicines) and suggested supporting resources.

Conclusion Participants provided insights into applying MATCH-D in practice and suggested resources to be included in an accompanying toolkit. These data provide external validation of MATCH-D and an empiric basis for their translation to practice. Following resource development, we plan to evaluate the feasibility and efficacy of implementation in practice.

  • dementia
  • potentially inappropriate medication list
  • inappropriate prescribing
  • deprescribing
  • cognitive impairment

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:

View Full Text

Statistics from


  • Contributors AP, CE-B, KP, RC, AM and CR designed the study. AP acted as chief investigator and drafted the funding application and Human Research Ethics Committee application. AP undertook recruitment along with the three Master of Pharmacy students (VC, XH, SK). AP drafted the protocol and the topic guide for the focus groups. LS moderated the focus groups as an independent facilitator. VC, XH and SK transcribed the focus groups. AP, VC, XH and SK undertook the qualitative analysis. AP drafted the manuscript for the published study. CE-B, RC, KP, AM, LS, CR, NP provided critical review and assistance with revisions.

  • Funding AP was funded by a University Postgraduate Award from the University of Western Australia. The Dementia Collaborative Research Centre supported this research through a competitive grant.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Ethics approval University of Western Australia.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement Data collected and analysed for this research are available by emailing the corresponding author Amy Page,

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.